Keyphrases
Glucagon-like
100%
Dipeptidyl peptidase-4 (DPP-4)
47%
Type 2 Diabetic Patients
33%
Glucose-dependent Insulinotropic Polypeptide
32%
Glucagon
31%
Incretin Hormones
28%
Type 2 Diabetes Mellitus (T2DM)
26%
Sitagliptin
21%
Insulin
17%
Type 2 Diabetes Prevention
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
59%
Glucagon-Like Peptide-1
54%
Dipeptidyl Peptidase IV Inhibitor
42%
Incretin
35%
Gastric Inhibitory Polypeptide
26%
Dipeptidyl Peptidase IV
25%
Medicine and Dentistry
Glucagon Like Peptide 1
46%
Incretin
38%
Dipeptidyl Peptidase-4 Inhibitor
31%
Maturity Onset Diabetes of the Young
27%
Gastric Inhibitory Polypeptide
24%
Patient with Type 2 Diabetes
22%